companydata.dkPerfusion Tech ApS: Financial statements 2019
CVR: 38238213
Perfusion Tech ApS (CVR 38238213) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -538,894 and a net result of DKK -596,373 compared with DKK -238,245 the year before. Equity amounted to DKK -329,031. The company had 1 employee in the financial year.
- Gross Profit
- -538,894 kr.
- Profit/Loss
- -596,373 kr.
- Equity
- -329,031 kr.
- Total Assets
- 621,530 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -539 t. | -596 t. | -329 t. | 1 |
| 2018 | - | -262 t. | -238 t. | -453 t. | - |
| 2017 | - | -278 t. | -272 t. | -214 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
As of November 14, 2019, EY Godkendt Revisionspartnerselskab has been appointed auditor of Perfusion Tech ApS.
As of November 14, 2019, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Perfusion Tech ApS.
Perfusion Tech ApS has published its annual report for 2018. Gross profit came to DKK -261,728, and the net result was DKK -238,245.
About Perfusion Tech ApS
Perfusion Tech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Perfusion Tech IVS. The management consists of Declan Cassells. The company is owned by Renew Pharmaceuticals Limited. In 2025, the company reported a gross profit of DKK -6,142,804 and a net result of DKK -12,724,708 compared with DKK -14,469,520 the year before. Equity amounted to DKK -9,640,655.